4//SEC Filing
Amman Bradford K. 4
Accession 0001493152-21-021915
CIK 0001716166other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 9:27 PM ET
Size
13.1 KB
Accession
0001493152-21-021915
Insider Transaction Report
Form 4
Amman Bradford K.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-11-18$7.50/sh+16,667$125,003→ 16,667 totalExercise: $7.50Exp: 2024-11-18→ Common Stock (16,667 underlying) - Award
Stock Option (Right to Buy)
2018-10-22$7.50/sh+83,334$625,005→ 83,334 totalExercise: $7.50Exp: 2023-10-22→ Common Stock (83,334 underlying) - Award
Stock Option (Right to Buy)
2021-08-31$5.26/sh+50,000$263,000→ 50,000 totalExercise: $5.26Exp: 2026-08-31→ Common Stock (50,000 underlying) - Award
Stock Option (Right to Buy)
2021-03-12$7.50/sh+100,000$750,000→ 100,000 totalExercise: $7.50Exp: 2026-03-12→ Common Stock (100,000 underlying)
Holdings
- 2,000
Common Stock
Footnotes (4)
- [F1]50,000 stock options granted on August 31, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through August 31, 2025.
- [F2]100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025.
- [F3]16,667 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through November 18, 2023.
- [F4]83,334 stock options granted on October 22, 2018. One-fifth vested immediately and one-fifth vests annually on each anniversary date through October 22, 2022
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001425339
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 9:27 PM ET
- Size
- 13.1 KB